The pathogenesis of acute COVID-19 invasion progresses with the binding of spike (S) glycoprotein to the angiotensin-converting enzyme (ACE2) receptor present primarily on lung epithelial cells, leading to the blockade of innate immunity and evasion of adaptive immunity, followed by subsequent acute and long-term sequelae [2]. This evidence concerns the gene ACE and COVID-19.